theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Medical Oncology

ctDNA   

Questions discussed in this category


How do you approach early-stage breast cancer patients who are asking for ctDNA or tumor marker surveillance (or previously receiving these with another provider) when these are not part of the NCCN or ASCO guidelines?
2 Answers available

For patients with resected colon cancer, to what extent would you adapt adjuvant chemotherapy if ctDNA results don't correspond with your initial treatment recommendation?
3 Answers available

How would positive ctDNA results after 12 cycles of adjuvant FOLFOX affect your management for patients with colon cancer?
4 Answers available

How, if at all, are you employing ctDNA in the management of patients with colon cancer?
1 Answer available
22020176051337017870


Papers discussed in this category


N Engl J Med, 2022 Jun 04
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.

JCO precision oncology, 2022 Jul
Reply to F. Dayyani et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023 May 15
Oxaliplatin in Adjuvant Colorectal Cancer: Is There a Role in Older Patients?

Related Topics in Medical Oncology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers

Copyright © 2025 theMednet
All Rights Reserved.